- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03147729
Radiofrequency in Anal Incontinence: Randomized Clinical Trials
May 8, 2017 updated by: Juliana Barros Ferreira, Escola Bahiana de Medicina e Saude Publica
Anal incontinence (AI) is used to englobe the involuntary loss of both fecal material and gases, which can help to improve quality of life.
Based on these experiences objectives were drawn: to evaluate the effectiveness of radiofrequency and it's influence on quality of life of patients with anal incontinence, to correlate the anal incontinence severity and to evaluate a sexual function and to verify an influence with radiofrequency treatment.
It is a blind randomized clinical trial.
For the collection of data it was used a fecal quality of life questionnaire (FIQL).
The questionnaire assess the severity of Anal Incontinence (FISI), the degree of patient's satisfaction using a five-point scale (Likert) and a visual analogue EVA scale).
It was divided in two groups, in one group it was used radiofrequency and pelvic exercises and in the other turned off radiofrequency (heated glycerin) and pelvic exercises.
It was accomplished in eight sections.
As a result, it is expected the efficiency of the treatment of radiofrequency in the quality of life, in sexual function and in it's severity.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
BA
-
Salvador/, BA, Brazil, 40290-000
- Escola bahiana de Medicina e Saúde Pública
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 66 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Individuals between 18 and 66 years of age with a clinical complaint of Anal Incontinence and who agree to participate voluntarily in the research.
Exclusion Criteria:
- Individuals with cognitive impairment, use of pacemakers, women who use the Intra-Uterine Device (IUD) of copper, pregnant women, individuals who are taking vasodilators or anticoagulants and hemophiliacs, patients with cognitive deficits or psychiatric illness, patients with chronic neurological degenerative diseases and individuals with hemorrhoid metallic clamp.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Radiofrequency in anal incontinence: a pilot study
It will be a single arm study with a group of anal incontinence with 10 women with anal incontinence
|
Use of radiofrequency
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The effectiveness of radiofrequency in anal incontinence
Time Frame: 8 radiofrequency sessions will be performed, with a 7 day interval between them. The session will be 20 minutes.Participants will be followed up for a minimum of 12 months.
|
The radiofrequency application protocol will be used in the form of a capacitive electric transfer, bipolar configuration, with the Tonderm brand, Spectra G2 model, which has two electrodes: one active, in the anal region, with liquid glycerin and another, dispersive, coupled to the patient's hip.
The temperature will be measured through a digital thermometer with infra-red until it reaches 41°C and will be maintained for 2 minutes.
It will use Consent form, questionnaire of socio-demographic data and basic anamnesis.
Then Fecal Incontinence Quality of Life, Fecal Incontinence Severity Index and Female Sexual Function Index.
After, a perineal physical evaluation will be performed by an experienced Physical Therapist.
The professional will perform a perineal muscle strength test, reflex and sensitivity test.
For the sensitivity evaluation will be used a digital osiometer.
The patients will be divided into two groups.
|
8 radiofrequency sessions will be performed, with a 7 day interval between them. The session will be 20 minutes.Participants will be followed up for a minimum of 12 months.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2015
Primary Completion (Actual)
May 3, 2017
Study Completion (Anticipated)
December 30, 2017
Study Registration Dates
First Submitted
May 4, 2017
First Submitted That Met QC Criteria
May 8, 2017
First Posted (Actual)
May 10, 2017
Study Record Updates
Last Update Posted (Actual)
May 10, 2017
Last Update Submitted That Met QC Criteria
May 8, 2017
Last Verified
May 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CAAE: 43462915.8.0000.554 4
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Publication in scientific articles.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Radiation Exposure
-
Instituto de Cardiologia do Rio Grande do SulCompletedRadiation Injury | Exposure to Ionizing Radiation | Occupational Exposure to RadiationBrazil
-
Maimonides Medical CenterRecruitingRadiation ExposureUnited States
-
Yonsei UniversityMyung In PharmRecruitingRadiation ExposureKorea, Republic of
-
Centre Hospitalier Universitaire de NīmesRecruiting
-
Helsinki University Central HospitalCompletedRadiation ExposureFinland
-
Azienda ULSS 3 SerenissimaUnknownRadiation Exposure
-
Ospedale Sandro Pertini, RomaCompleted
-
Yale UniversityCompletedRadiation ExposureUnited States
-
Bracco Diagnostics, IncCompletedRadiation ExposureUnited States
-
IRCCS San RaffaeleNot yet recruiting
Clinical Trials on Radiofrequency non ablation
-
Assistance Publique - Hôpitaux de ParisTerminatedHepatocellular CancerFrance
-
Xijing HospitalUnknown
-
Oxford University Hospitals NHS TrustRoyal Bournemouth and Christchurch Hospitals NHS Foundation TrustCompleted
-
Allevio Pain Management ClinicRecruitingShoulder Pain Chronic | Faceto-genic Neck Pain | Faceto-genic HeadacheCanada
-
Southwest Hospital, ChinaCompleted
-
Mansoura UniversityUnknownChronic Knee OsteoarthritisEgypt
-
Texas Cardiac Arrhythmia Research FoundationUniversity of Texas at AustinUnknownChronic Atrial FibrillationUnited States
-
University of CalgaryRecruitingOsteoarthritis, KneeCanada
-
Assistance Publique - Hôpitaux de ParisCompletedHepatocellular CarcinomasFrance
-
Aalborg University HospitalOdense University Hospital; St. Antonius HospitalTerminatedParoxysmal Atrial Fibrillation.Netherlands, Denmark